We are committed to providing our patients with innovative and science-based therapies to support healthy, sustainable weight loss and overall metabolic wellness
Your healthcare professional will also order fasting blood glucose and hemoglobin A1c periodically to assess how diabetes is controlled
Key safety monitoring parameters include: Baseline and periodic assessment of nutritional status (complete blood count, comprehensive metabolic panel, vitamin levels, albumin) Renal function monitoring, particularly during dose escalation, due to risk of acute kidney injury from dehydration Evaluation for gastrointestinal symptoms and differentiation from surgical complications Monitoring for gallbladder disease, which may be increased with weight loss and semaglutide use Assessment of medication adherence and injection technique Eye examination in patients with diabetes due to potential risk of diabetic retinopathy progression with rapid glycemic improvement Regular follow-up with both bariatric surgery and endocrinology or obesity medicine teams when possible Patients should be counseled to report severe or persistent nausea, vomiting, abdominal pain, or inability to maintain adequate hydration or nutrition, as these may warrant dose adjustment, temporary discontinuation, or further evaluation for surgical complications
it represents flexible strategies some clinicians or patients experiment with to improve tolerability
50,51 The initial dosing regimen of tirzepatide is 2.5 mg weekly, with the dose increased to up to 15 mg weekly usually after one month at the previous dose
Mild soreness or redness at the site is normal
